Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Debt Ratio: 2013-2025

Historic Debt Ratio for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Sep 2025 value amounting to 0.37.

  • Amphastar Pharmaceuticals' Debt Ratio fell 5.27% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 5.27%. This contributed to the annual value of 0.38 for FY2024, which is 2.17% down from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Debt Ratio stood at 0.37, which was down 2.92% from 0.38 recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Debt Ratio high stood at 0.41 for Q3 2023, and its period low was 0.06 during Q2 2021.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Debt Ratio value was 0.38 (recorded in 2024), while the average stood at 0.36.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Debt Ratio dropped by 25.62% in 2021, and later surged by 296.95% in 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Debt Ratio (MRQ) stood at 0.11 in 2021, then dropped by 10.78% to 0.10 in 2022, then soared by 281.32% to 0.39 in 2023, then decreased by 2.17% to 0.38 in 2024, then dropped by 4.12% to 0.37 in 2025.
  • Its Debt Ratio stands at 0.37 for Q3 2025, versus 0.38 for Q2 2025 and 0.37 for Q1 2025.